Publié le March 30, 2023
Abstract: Purpose Pathologic complete response (pCR) has prognostic importance and is frequently used as a primary end point, but doubts…
Lire la suite
Publié le February 27, 2023
Strategic partnership to pair long-standing clinical research expertise with a best-in-class RTSM system
Lire la suite
Publié le December 20, 2022
Discover how IDDI biostatistics-driven RTSM helped the Sponsor to avoid serious imbalance between the two randomized arms for the treated…
Lire la suite
Publié le December 19, 2022
Discover how a Sponsor reached the overall balance amongst 2 arms by adding a stratification factor.
Lire la suite
Publié le December 19, 2022
Discover how a Sponsor optimized the drug delivery via IDDI’s Proposition of a Predictive Drug Supply Model. PLEASE FILL IN…
Lire la suite
Publié le December 12, 2022
Randomized controlled trials (RCTs), particularly in phase 3, are the preferred sources of evidence for drug approval and reimbursement decisions….
Lire la suite
Publié le June 29, 2022
Generalized Pairwise Comparisons – GPC Today’s session is focusing on an innovative statistical methodology called Generalized Pairwise Comparisons – or…
Lire la suite
Publié le June 22, 2022
PRESS RELEASE Clario to deliver industry leading Randomization, Trial Supply and Management SaaS for new partnership with IDDI Use of…
Lire la suite
Publié le February 21, 2022
Phase I/II study in cancer patients showcases eClinical effectiveness. An Article written by IDDI Published in Applied Clinical Trials, February…
Lire la suite
Publié le January 4, 2022
Join IDDI experts to get updated on efficacy assessment in early-phase trials and more! THURSDAY, FEBRUARY 3 – 9:00 –…
Lire la suite